Many women who are faced with crohn's disease are prescribed a medication called Adalimumab (ADA). This medication helps to lower the inflammation, yet is may lower the immune system response. The medication messes with parts of the immune system and therefore the people on it have a higher risk for infection. Last year, they discovered that women on the drug who are pregnant can be passing this drug into the fetus. In the third trimester of pregnancy, the drug passes through the chord across the placenta. Babies that are born have the drug in their blood for at least 3 months after birth. This is a cause for concern and extra monitoring since the baby may now be more prone to infection. It is also reccommended not to give the baby any virus immunizations until it is out of his system. No one said that a woman who is pregnant should not take the drug, since there are more serious dangers for her and the baby if she were to stop the drug. This is something to be aware of and not something to be so scared of. With the proper awareness, it is possible to prevent any problems from occuring to the baby.
http://www.sciencedaily.com/releases/2011/05/110508134939.htm
No comments:
Post a Comment